hematological predictors of thrombotic risk or disease progression in essential thrombocythemia
Published 6 months ago • 1K plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
1:34
are thrombotic risk and progression in et predictable?
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:57
surpass et: p1101 in essential thrombocythemia
-
3:26
the risk of thrombotic events in patients with mgus: an analysis from the istopmm trial
-
8:07
essential thrombocythemia: outcomes, unmet needs, and therapeutic strategies
-
29:13
essential thrombocythemia: pathogenesis and management
-
27:18
evaluation of the bleeding patient: screening tests
-
12:05
our heavy metal detox experience | bumblebee apothecary
-
14:42
hematology in 10 min: anticoagulation therapy for venous thromboembolism
-
2:16
determining when to switch from hydroxyurea to interferon-based therapy in patients with pv
-
1:25
the current approach to managing patients with prefibrotic pmf
-
4:02
mpns and thrombosis: reducing the risk
-
6:58
blood review series – emerging immunotherapies for hematologic diseases
-
1:52
the role of thromboinflammation in chronic mpns
-
1:05:23
haematology week 2 - vaccine induced thrombotic thrombocytopenia (vitt)
-
0:52
insights from advance iv study: efgartigimod increases platelet counts of patients with itp
-
4:06
the impact of rbps in the development of hematological malignancies and bone marrow failure
-
3:59
the ash agenda for hematology research: venous thromboembolism
-
2:47
using artificial intelligence to estimate overall mortality and non-relapse mortality after allosct
-
3:37
biomarker analysis of luspatercept versus epoetin alfa in lr-mds in the phase iii commands study
-
1:27
current diagnostic modalities for the identification of ptld